<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00249873</url>
  </required_header>
  <id_info>
    <org_study_id>EFC4912 A</org_study_id>
    <nct_id>NCT00249873</nct_id>
  </id_info>
  <brief_title>Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)</brief_title>
  <official_title>A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the combination of clopidogrel 75mg once daily
      (od) plus aspirin 100mg daily (recommended dose) is better than aspirin alone (100mg daily
      recommended dose) for preventing vascular events such as stroke and heart attack during
      approximately three years of follow-up in patients with atrial fibrillation associated with
      at least one major risk factor of vascular event such as elderly, blood pressure increase,
      history of stroke or transient ischemic attack or left ventricular dysfunction etc. The study
      will also accept patients with atrial fibrillation and unwilling to take oral anticoagulant
      therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2003</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First Occurence of Any Component of the Composite of Stroke, Non-Central Nervous System (Non-CNS) Systemic Embolism, Myocardial Infarction or Vascular Death as Per Adjudication</measure>
    <time_frame>expected median follow-up of approximately 3 years</time_frame>
    <description>The primary event is the first occurence of any adjudicated component of the following cluster over the duration of follow-up :
stroke (nonfatal or fatal)
myocardial infarction (nonfatal or fatal)
non-CNS systemic embolism
vascular death
The primary efficacy analysis is performed on the time from randomization to this primary event. Numbers of patients with the composite event over the duration of the follow-up are presented by arm group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of Stroke</measure>
    <time_frame>expected median follow-up of approximately 3 years</time_frame>
    <description>The event is the occurence of stroke (nonfatal or fatal, ischemic, hemorrhagic or of uncertain type) after validation of the Event Adjudication Committee . The analysis is performed on the time from randomization to the occurrence of this event. Numbers of patients with the event over the duration of the follow-up are presented by arm group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death From Any Cause (Cardiovascular and Noncardiovascular)</measure>
    <time_frame>expected median follow-up of approximately 3 years</time_frame>
    <description>The considered event is death from any cause. The analysis is performed on the time from randomization to this event. Numbers of patients with the event over the duration of the follow-up are presented by arm group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adjudicated Major Bleedings</measure>
    <time_frame>expected median follow-up of approximately 3 years</time_frame>
    <description>The number of participants with at least one major bleeding, validated by the Event Adjudication Committee are counted over the duration of the follow-up (including after permanent discontinuation of the study drug).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">7554</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Vascular Risk</condition>
  <arm_group>
    <arm_group_label>Clopidogrel + ASA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clopidogrel 75 mg once daily (od) plus acetylsalicyclic acid (ASA) 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo + ASA</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo of clopidogrel 75 mg od plus acetylsalicyclic acid (ASA) 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>clopidogrel (SR25990C)</intervention_name>
    <description>oral administration (tablets)</description>
    <arm_group_label>Clopidogrel + ASA</arm_group_label>
    <other_name>PlavixÂ®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>oral administration (tablets)</description>
    <arm_group_label>Placebo + ASA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        To be eligible for ACTIVE A patients must have in same time the three following conditions
        :

          -  Evidence of atrial fibrillation either on one current Electrocardiogram (ECG) or two
             ECGs recorded at two weeks a part during 6 months prior to study enrollment.

          -  Evidence of high risk of vascular events : at least one of the following risk criteria
             must be present :

               -  are 75 years greater;

               -  on treatment for systemic hypertension;

               -  prior stroke, Transient Ischemic Attack (TIA) or non-Central Nervous System
                  (non-CNS) systemic embolus;

               -  left ventricular dysfunction with left ventricular ejection fraction (EF)
                  estimated by echocardiogram or angiogram (radionuclide or contrast) to be &lt; 45%;

               -  peripheral vascular disease (previous peripheral artery revascularization, limb
                  and foot amputation, or the combination of current intermittent claudication and
                  ankle arm systolic blood pressure ratio &lt; 0.9);

               -  age 55 to 74 years and either; f1) diabetes mellitus requiring drug therapy, or
                  f2) documented previous myocardial infarction or documented coronary artery
                  disease.

          -  To have either a contraindication to use an oral anticoagulant treatment or they are
             unwilling to take an oral anticoagulant treatment.

        Exclusion Criteria:

        Patients will be excluded from ACTIVE if any of the following are present :

          -  requirement for clopidogrel (such as recent coronary stent procedure)

          -  requirement for oral anticoagulant (such as prosthetic mechanical heart valve);

          -  prior intolerance to ASA or clopidogrel;

          -  documented peptic ulcer disease within the previous 6 months;

          -  prior intracerebral hemorrhage;

          -  significant thrombocytopenia; (platelet count &lt; 50 x 10(9)/L)

          -  psychosocial reason making study participation impractical;

          -  geographic reason making study participation impractical;

          -  ongoing alcohol abuse;

          -  mitral stenosis,

          -  pregnant or nursing woman or woman of child bearing potential and not on effective
             birth control for at least one month prior to start of study or not willing to
             continue on birth control for duration of study; (severe comorbid condition such that
             the patient is not expected to survive 6 months;

          -  patient currently receiving an investigational pharmacologic agent;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe YUSUF, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Hamilton Health Sciences Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Bridgewater</city>
        <state>New Jersey</state>
        <zip>08807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Macquarie Park</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-aventis Administrative Office</name>
      <address>
        <city>Diegem</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Laval</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Horsholm</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Causeway Bay</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Mexico</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Gouda</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Lysaker</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Porto Salvo</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Midrand</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Bromma</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Geneva</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Guildford Surrey</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hong Kong</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Singapore</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Israel</country>
    <country>Russian Federation</country>
    <country>Turkey</country>
  </removed_countries>
  <results_reference>
    <citation>ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009 May 14;360(20):2066-78. doi: 10.1056/NEJMoa0901301. Epub 2009 Mar 31.</citation>
    <PMID>19336502</PMID>
  </results_reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2005</study_first_submitted>
  <study_first_submitted_qc>November 4, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2005</study_first_posted>
  <results_first_submitted>March 8, 2010</results_first_submitted>
  <results_first_submitted_qc>March 8, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 26, 2010</results_first_posted>
  <last_update_submitted>May 20, 2015</last_update_submitted>
  <last_update_submitted_qc>May 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Anticoagulant therapy</keyword>
  <keyword>Thromboembolic prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clopidogrel</mesh_term>
    <mesh_term>Ticlopidine</mesh_term>
    <mesh_term>Irbesartan</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were enrolled from June 2003 until May 2006. The study was conducted at 580 centers in 33 countries. The planned final follow-up visit date ensuring a median follow-up of three years was November 2008. The follow-up of the study was actually completed on March 2009 corresponding to an actual median follow-up of 3.5 years.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Clopidogrel + ASA</title>
          <description>Clopidogrel 75 mg once daily (od) plus acetylsalicyclic acid (ASA) 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
        </group>
        <group group_id="P2">
          <title>Placebo + ASA</title>
          <description>Matching placebo of clopidogrel 75 mg od plus ASA 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3772">randomized patients: patients remained in the study whether treated or not until planned study end</participants>
                <participants group_id="P2" count="3782">randomized patients: patients remained in the study whether treated or not until planned study end</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2442">started and completed study drug</participants>
                <participants group_id="P2" count="2528">started and completed study drug</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1330"/>
                <participants group_id="P2" count="1254"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Not treated</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Significant thrombocytopenia</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Severe allergic reaction</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Serious haemorrhagic Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="74"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Serious Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="86"/>
                <participants group_id="P2" count="97"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Qualifying condition not present</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Contraindication to oral anticoagulant</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="504"/>
                <participants group_id="P2" count="466"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Minor bleeding</title>
              <participants_list>
                <participants group_id="P1" count="99"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-compliance</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="46"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other non serious Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="112"/>
                <participants group_id="P2" count="108"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other contraindicated medication</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Patient not wish to continue after May08</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician withdrew consent</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Open label clopidogrel required</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="42"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Angiotensin II receptor blocker required</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Oral anticoagulant required</title>
              <participants_list>
                <participants group_id="P1" count="159"/>
                <participants group_id="P2" count="157"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study drug intolerance</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Surgery/ procedure</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Event related to cardiac condition</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Thromboembolic/outcome event</title>
              <participants_list>
                <participants group_id="P1" count="82"/>
                <participants group_id="P2" count="122"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Clopidogrel + ASA</title>
          <description>Clopidogrel 75 mg once daily (od) plus acetylsalicyclic acid (ASA) 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
        </group>
        <group group_id="B2">
          <title>Placebo + ASA</title>
          <description>Matching placebo of clopidogrel 75 mg od plus ASA 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3772"/>
            <count group_id="B2" value="3782"/>
            <count group_id="B3" value="7554"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>18 to &lt;65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="931"/>
                    <measurement group_id="B2" value="935"/>
                    <measurement group_id="B3" value="1866"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>65 to &lt;75 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1291"/>
                    <measurement group_id="B2" value="1258"/>
                    <measurement group_id="B3" value="2549"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;= 75 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1550"/>
                    <measurement group_id="B2" value="1589"/>
                    <measurement group_id="B3" value="3139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70.9" spread="10.2"/>
                    <measurement group_id="B2" value="71.1" spread="10.2"/>
                    <measurement group_id="B3" value="71.0" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1560"/>
                    <measurement group_id="B2" value="1597"/>
                    <measurement group_id="B3" value="3157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2212"/>
                    <measurement group_id="B2" value="2185"/>
                    <measurement group_id="B3" value="4397"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>CHADS2 Score</title>
          <description>CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                    <measurement group_id="B2" value="101"/>
                    <measurement group_id="B3" value="206"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1360"/>
                    <measurement group_id="B2" value="1338"/>
                    <measurement group_id="B3" value="2698"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1263"/>
                    <measurement group_id="B2" value="1315"/>
                    <measurement group_id="B3" value="2578"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1040"/>
                    <measurement group_id="B2" value="1028"/>
                    <measurement group_id="B3" value="2068"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sitting Systolic Blood Pressure</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;120 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="603"/>
                    <measurement group_id="B2" value="620"/>
                    <measurement group_id="B3" value="1223"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=120 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3166"/>
                    <measurement group_id="B2" value="3159"/>
                    <measurement group_id="B3" value="6325"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/mÂ²</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.370" spread="5.575"/>
                    <measurement group_id="B2" value="28.459" spread="6.022"/>
                    <measurement group_id="B3" value="28.415" spread="5.803"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>First Occurence of Any Component of the Composite of Stroke, Non-Central Nervous System (Non-CNS) Systemic Embolism, Myocardial Infarction or Vascular Death as Per Adjudication</title>
        <description>The primary event is the first occurence of any adjudicated component of the following cluster over the duration of follow-up :
stroke (nonfatal or fatal)
myocardial infarction (nonfatal or fatal)
non-CNS systemic embolism
vascular death
The primary efficacy analysis is performed on the time from randomization to this primary event. Numbers of patients with the composite event over the duration of the follow-up are presented by arm group.</description>
        <time_frame>expected median follow-up of approximately 3 years</time_frame>
        <population>The intent-to-treat (ITT) population was used for all analyses. This consisted of all randomized patients irrespective of whether or not the patient actually received study drug or the patientâs compliance with the study protocol. All patients were included in the treatment group to which they were originally allocated.</population>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel + ASA</title>
            <description>Clopidogrel 75 mg once daily (od) plus acetylsalicyclic acid (ASA) 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
          </group>
          <group group_id="O2">
            <title>Placebo + ASA</title>
            <description>Matching placebo of clopidogrel 75 mg od plus ASA 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
          </group>
        </group_list>
        <measure>
          <title>First Occurence of Any Component of the Composite of Stroke, Non-Central Nervous System (Non-CNS) Systemic Embolism, Myocardial Infarction or Vascular Death as Per Adjudication</title>
          <description>The primary event is the first occurence of any adjudicated component of the following cluster over the duration of follow-up :
stroke (nonfatal or fatal)
myocardial infarction (nonfatal or fatal)
non-CNS systemic embolism
vascular death
The primary efficacy analysis is performed on the time from randomization to this primary event. Numbers of patients with the composite event over the duration of the follow-up are presented by arm group.</description>
          <population>The intent-to-treat (ITT) population was used for all analyses. This consisted of all randomized patients irrespective of whether or not the patient actually received study drug or the patientâs compliance with the study protocol. All patients were included in the treatment group to which they were originally allocated.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3772"/>
                <count group_id="O2" value="3782"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All components</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="832"/>
                    <measurement group_id="O2" value="924"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>- Myocardial Infarction (fatal or not)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84"/>
                    <measurement group_id="O2" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>- Stroke (fatal or not)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="285"/>
                    <measurement group_id="O2" value="391"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>- Non-CNS systemic embolism</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>- Vascular death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="413"/>
                    <measurement group_id="O2" value="380"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0133</p_value>
            <p_value_desc>Cumulative incidence functions in each treatment group were calculated using non-parametric Kaplan-Meier estimates. Median time-to-event was not reached in any group. The primary comparison was performed at the 5% level using a 2-sided Log rank test.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.89</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
            <estimate_desc>The hazard ratio was estimated by a Cox's proportional hazard model with treatment arm factor. It represents the relative hazard of any component of the primary event for the clopidogrel group compared with the Placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Occurrence of Stroke</title>
        <description>The event is the occurence of stroke (nonfatal or fatal, ischemic, hemorrhagic or of uncertain type) after validation of the Event Adjudication Committee . The analysis is performed on the time from randomization to the occurrence of this event. Numbers of patients with the event over the duration of the follow-up are presented by arm group.</description>
        <time_frame>expected median follow-up of approximately 3 years</time_frame>
        <population>The intent-to-treat (ITT) population was used for this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel + ASA</title>
            <description>Clopidogrel 75 mg once daily (od) plus acetylsalicyclic acid (ASA) 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
          </group>
          <group group_id="O2">
            <title>Placebo + ASA</title>
            <description>Matching placebo of clopidogrel 75 mg od plus ASA 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of Stroke</title>
          <description>The event is the occurence of stroke (nonfatal or fatal, ischemic, hemorrhagic or of uncertain type) after validation of the Event Adjudication Committee . The analysis is performed on the time from randomization to the occurrence of this event. Numbers of patients with the event over the duration of the follow-up are presented by arm group.</description>
          <population>The intent-to-treat (ITT) population was used for this analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3772"/>
                <count group_id="O2" value="3782"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="296"/>
                    <measurement group_id="O2" value="408"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Cumulative incidence functions in each treatment group were calculated using non-parametric Kaplan-Meier estimates. Median time-to-event was not reached in any group. The primary comparison was performed at the 5% level using a 2-sided Log rank test.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.62</ci_lower_limit>
            <ci_upper_limit>0.83</ci_upper_limit>
            <estimate_desc>The hazard ratio was estimated by a Cox's proportional hazard model with treatment arm factor. It represents the relative hazard of stroke for the clopidogrel group compared with the Placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Death From Any Cause (Cardiovascular and Noncardiovascular)</title>
        <description>The considered event is death from any cause. The analysis is performed on the time from randomization to this event. Numbers of patients with the event over the duration of the follow-up are presented by arm group.</description>
        <time_frame>expected median follow-up of approximately 3 years</time_frame>
        <population>The intent-to-treat (ITT) population was used for the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel + ASA</title>
            <description>Clopidogrel 75 mg once daily (od) plus acetylsalicyclic acid (ASA) 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
          </group>
          <group group_id="O2">
            <title>Placebo + ASA</title>
            <description>Matching placebo of clopidogrel 75 mg od plus ASA 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
          </group>
        </group_list>
        <measure>
          <title>Death From Any Cause (Cardiovascular and Noncardiovascular)</title>
          <description>The considered event is death from any cause. The analysis is performed on the time from randomization to this event. Numbers of patients with the event over the duration of the follow-up are presented by arm group.</description>
          <population>The intent-to-treat (ITT) population was used for the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3772"/>
                <count group_id="O2" value="3782"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="825"/>
                    <measurement group_id="O2" value="841"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.696</p_value>
            <p_value_desc>Cumulative incidence functions in each treatment group were calculated using non-parametric Kaplan-Meier estimates. Median time-to-event was not reached in any group. The primary comparison was performed at the 5% level using a 2-sided Log rank test.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.98</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.89</ci_lower_limit>
            <ci_upper_limit>1.08</ci_upper_limit>
            <estimate_desc>The hazard ratio was estimated by a Cox's proportional hazard model with treatment arm factor. It represents the relative hazard of death from any cause for the clopidogrel group compared with the Placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adjudicated Major Bleedings</title>
        <description>The number of participants with at least one major bleeding, validated by the Event Adjudication Committee are counted over the duration of the follow-up (including after permanent discontinuation of the study drug).</description>
        <time_frame>expected median follow-up of approximately 3 years</time_frame>
        <population>The intent-to-treat (ITT) population was used for the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel + ASA</title>
            <description>Clopidogrel 75 mg once daily (od) plus acetylsalicyclic acid (ASA) 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
          </group>
          <group group_id="O2">
            <title>Placebo + ASA</title>
            <description>Matching placebo of clopidogrel 75 mg od plus ASA 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
          </group>
        </group_list>
        <measure>
          <title>Adjudicated Major Bleedings</title>
          <description>The number of participants with at least one major bleeding, validated by the Event Adjudication Committee are counted over the duration of the follow-up (including after permanent discontinuation of the study drug).</description>
          <population>The intent-to-treat (ITT) population was used for the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3772"/>
                <count group_id="O2" value="3782"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="251"/>
                    <measurement group_id="O2" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From randomization through 28 days after the end of study drug treatment or the final follow-up visit. In both treatment groups, median duration of exposure was approximately 36 months, with a maximum of 62 months.</time_frame>
      <desc>The intent to treat population was also used for safety analyses.</desc>
      <group_list>
        <group group_id="E1">
          <title>Clopidogrel + ASA</title>
          <description>Clopidogrel 75 mg once daily (od) plus acetylsalicyclic acid (ASA) 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
        </group>
        <group group_id="E2">
          <title>Placebo + ASA</title>
          <description>Matching placebo of clopidogrel 75 mg od plus ASA 75 to 100 mg od recommended (dose at the investigators' discretion)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (11.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1154" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1069" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Anaemia megaloblastic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Anaemia of chronic disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Anaemia of malignant disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemorrhagic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypochromic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Nephrogenic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cardiac amyloidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pericardial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Sinoatrial block</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tricuspid valve disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Adenomatous polyposis coli</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dermoid cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Muscular dystrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Phimosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness neurosensory</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hearing impaired</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Sudden hearing loss</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vestibular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Autoimmune thyroiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diabetes insipidus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Ectopic hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism secondary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thyroiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Toxic nodular goitre</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Angle closure glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Corneal degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Eyelid oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Maculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pupils unequal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Retinal degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Retinal vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Abdominal strangulated hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Anal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Barrett's oesophagus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Coeliac disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colonic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diarrhoea haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diverticulitis intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Enterocolitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Femoral hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Femoral hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gallstone ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastric antral vascular ectasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastric mucosal lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastroduodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastrooesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Inguinal hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intestinal dilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intestinal functional disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intestinal polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intestinal strangulation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Large intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Mallory-weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Mechanical ileus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Mesenteric occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Oesophageal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Oesophageal varices haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Oesophagitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Peptic ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Peritoneal adhesions</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Rectal polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Rectal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Reflux oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Salivary gland calculus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tooth disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Umbilical hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pelvic mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Perforated ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Performance status decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Puncture site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Submandibular mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Alcoholic liver disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bile duct stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Biliary cirrhosis primary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cholangitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cirrhosis alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatic congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatic cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatic mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatitis alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatitis toxic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatocellular injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Post cholecystectomy syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Acarodermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>American trypanosomiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Anogenital warts</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Appendiceal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Biliary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Breast abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Central line infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Corneal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cryptosporidiosis infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dermo-hypodermitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Emphysematous cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Endocarditis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Enterocolitis infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Escherichia infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gallbladder empyema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastroenteritis norovirus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastroenteritis salmonella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatitis e</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Herpes zoster ophthalmic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Implant site infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Keratitis fungal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Peritoneal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pilonidal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pneumococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="139" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="128" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pneumonia klebsiella</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pneumonia primary atypical</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pneumonia streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Portal pyaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Post procedural sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pseudomonas infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Sepsis syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Skin bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Staphylococcal toxaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tetanus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis septic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Toxic shock syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urethritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Viral pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vulval abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Wound infection staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abdominal wound dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Anastomotic leak</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Anastomotic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Anastomotic ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Asbestosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dislocation of joint prosthesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Drug toxicity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Ear injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Epiphyseal fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Extradural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Fracture displacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Fractured coccyx</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Fractured sacrum</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Graft complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haematuria traumatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Heat exhaustion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator malfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Joint sprain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Muscle rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Open fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Open wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Operative haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pacemaker complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pharyngeal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Post-traumatic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Postoperative adhesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Postoperative renal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pubic rami fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Radiation mucositis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Scapula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Subcutaneous haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tendon injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Therapeutic agent toxicity</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Traumatic brain injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Traumatic haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Wound complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Aspiration bronchial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Carbohydrate tolerance decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemosiderosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypoalbuminaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Iron deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Metabolic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Starvation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Underweight</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bunion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Chondrocalcinosis pyrophosphate</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dupuytren's contracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Finger deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Mobility decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="36" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Periostitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Senile osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Abdominal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Acute leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Adrenal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Basosquamous carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Benign anorectal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Benign lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Benign ovarian tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Biliary cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Biliary neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bladder papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bone sarcoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Brain neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Breast cancer female</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Breast cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Breast neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bronchioloalveolar carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cancer pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour of the stomach</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cervix carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cholesteatoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colon cancer stage iv</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colon neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colorectal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cystosarcoma phyllodes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Diffuse large b-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Duodenal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Endometrial cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gallbladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastric neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastrointestinal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stromal tumour</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Glioblastoma multiforme</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Glioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemangioma of liver</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intestinal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Large cell carcinoma of the respiratory tract stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Large granular lymphocytosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Large intestine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Leiomyosarcoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lymph node cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Malignant melanoma in situ</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Malignant soft tissue neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Mediastinum neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Metastases to adrenals</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Metastatic gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Metastatic squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Multiple myeloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Myelofibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Nasal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Neoplasm skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Neurilemmoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma of the skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Neuroma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Oral neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pancreatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pancreatic neuroendocrine tumour</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pelvic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Penis carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Peritoneal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pharyngeal cancer stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Plasmacytoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pleural mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Rectal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Rectosigmoid cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Salivary gland adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Salivary gland neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Sarcoma uterus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thyroid adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tumour haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vulval cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amyotrophic lateral sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cauda equina syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cerebral artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cerebral disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cerebral haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cervical root pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Encephalitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Extrapyramidal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Facial paresis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Grand mal convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Guillain-barre syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypokinesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intercostal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intracranial haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Ivth nerve paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Mental impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Mononeuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Nervous system disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Neurological decompensation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Optic neuritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Post herpetic neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Radicular syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Ruptured cerebral aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Simple partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Spinal cord compression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Status epilepticus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Syncope vasovagal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thalamus haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thrombotic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vascular dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vascular encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal behaviour</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bipolar i disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Delusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Delusional disorder, persecutory type</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Neurosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Panic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Schizophrenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Schizophrenia, paranoid type</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bladder neck sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bladder obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bladder stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cystitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cystitis noninfective</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cystitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Enuresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemorrhage urinary tract</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Obstructive uropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Ureteric obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urethral fistula</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urethral meatus stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urinary bladder haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urinary bladder polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urinary tract disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Breast mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cervical dysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Colpocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Endometrial atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Endometrial hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Fibrocystic breast disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Gynaecomastia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Prostatic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Prostatic haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Prostatism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Uterine enlargement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Uterine haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Uterine polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vaginal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Alveolitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bronchial disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bronchopneumopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pleural adhesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pulmonary haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pulmonary hilum mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Respiratory acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Status asthmaticus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thoracic haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Tonsillar disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemorrhage subcutaneous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pemphigoid</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Pustular psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Skin induration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Skin necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Skin ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Stasis dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Toxic skin eruption</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Bedridden</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Disability</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Elderly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Joint prosthesis user</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Social problem</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Social stay hospitalisation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Circumcision</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemorrhoid operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intestinal stoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Intraocular lens implant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Obesity surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Wound drainage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Angiodysplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Aortic rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis obliterans</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Bleeding varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Cardiovascular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Femoral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Varicose ulceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Venous insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (11.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2542" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="2502" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Any Cardiac disorders</sub_title>
                <counts group_id="E1" subjects_affected="301" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="314" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Any Eye disorders</sub_title>
                <counts group_id="E1" subjects_affected="190" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="198" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Any Gastrointestinal disorders</sub_title>
                <counts group_id="E1" subjects_affected="806" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="763" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Any General disorders and administration site conditions</sub_title>
                <counts group_id="E1" subjects_affected="582" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="541" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Any Infections and infestations</sub_title>
                <counts group_id="E1" subjects_affected="994" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="961" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Any Injury, poisoning and procedural complications</sub_title>
                <counts group_id="E1" subjects_affected="433" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="353" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Any Investigations</sub_title>
                <counts group_id="E1" subjects_affected="185" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="201" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Any Metabolism and nutrition disorders</sub_title>
                <counts group_id="E1" subjects_affected="239" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="257" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Any Musculoskeletal and connective tissue disorders</sub_title>
                <counts group_id="E1" subjects_affected="532" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="623" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Any Neoplasms benign, malignant and unspecified (incl cysts and polyps)</sub_title>
                <counts group_id="E1" subjects_affected="220" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="208" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Any Nervous system disorders</sub_title>
                <counts group_id="E1" subjects_affected="661" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="682" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="300" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="312" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Any Renal and urinary disorders</sub_title>
                <counts group_id="E1" subjects_affected="184" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="196" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Any Respiratory, thoracic and mediastinal disorders</sub_title>
                <counts group_id="E1" subjects_affected="538" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="510" subjects_at_risk="3782"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="231" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="215" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Any Skin and subcutaneous tissue disorders</sub_title>
                <counts group_id="E1" subjects_affected="337" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="289" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Any Vascular disorders</sub_title>
                <counts group_id="E1" subjects_affected="440" subjects_at_risk="3772"/>
                <counts group_id="E2" subjects_affected="414" subjects_at_risk="3782"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Publication of the study will be made jointly in the name of all wholehearted collaborators. Other papers will be authored based on the contributions of the individuals to the overall study. Substudies with scientific merit which have received prior approval from the Steering Committee (SC) may be published in the names of the contributing investigators. A copy of all manuscripts will be provided to the sponsors for their review. The final decision to publish articles will be made by the SC.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>International Clinical Development, Clinical Study Director</name_or_title>
      <organization>sanofi-aventis</organization>
      <email>GV-Contact-us@sanofi-aventis.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

